Skip to content
Biodatica
Start free

Investigator

Benjamin Solomon Freedman

UNIVERSITY OF WASHINGTON · funded by NIDDK, NIAID

Companies
2

Resolved onto their grants.

Grants
5

Federal awards on file.

Non-dilutive funding
$1.1M

Summed across those awards.

First award
May 1, 2023

Latest Sep 15, 2025.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. U54

    Polycystic Kidney Disease In Vitro Center (PKD-InVent)

    $414k

    Sep 15, 2025NIDDKUNIVERSITY OF WASHINGTONNIH RePORTER · 11231618 (opens the source filing in a new tab)

  2. U54

    Administrative Core

    $103k

    Sep 15, 2025NIDDKUNIVERSITY OF WASHINGTONNIH RePORTER · 11231619 (opens the source filing in a new tab)

  3. U2C

    Professional Development Core

    $97k

    Sep 1, 2024NIDDKUNIVERSITY OF WASHINGTONNIH RePORTER · 11168857 (opens the source filing in a new tab)

  4. U2C

    Professional Development Core

    $95k

    Sep 1, 2024NIDDKUNIVERSITY OF WASHINGTONNIH RePORTER · 11355663 (opens the source filing in a new tab)

  5. U01

    Utility of Human Organoids for Safety and Efficiency Evaluations of Genome Editing Therapeutics

    $342k

    May 1, 2023NIAIDUNIVERSITY OF WASHINGTONNIH RePORTER · 11075125 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources